People
The analysis found 13 key problems, but one of the most relevant is that the stated purpose of the research—which is also under attack—did not occur.
Phoenix Solutions AS, a clinical-stage biotech company, announced the appointment of Dr. Jean-Michel Cosséry to its Board of Directors.
InDevR, Inc., a life science tools company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced that Ms. Terry Salyer has joined the company as Chief Commercial Officer.
Researchers from around the world are coming to present scientific research and clinical trial data for the disease.
Richard Sackler, the former president of Purdue Pharma, wanted prescribers to know that when it comes to treating pain, OxyContin was the way to go. And, in order to boost those sales, that meant the company had to downplay any concerns regarding the risk of addiction.
Experienced financial leader joins Xenikos as they enter the final stage of clinical development of T-Guard®
Columbia, SC – Obsidio, Inc., a pre-clinical stage medical materials developer pioneering a universal embolic hydrogel designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion, announced the formation of its clinical advisory board.
Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.
Panthera Biopartners has strengthened its management team with the appointment of Jane Restorick as Chief Commercial Officer.
Pharma and life science companies strengthen their leadership teams and boards of directors with this week’s appointments.
PRESS RELEASES